Shauna M. Crowley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shauna M. Crowley has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Bruce Andrew Vallance
Department of Pediatrics, British Columbia (BC) Children's Hospital, University of British Columbia, Canada
3 shared publications - Caixia Ma
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, The University of British Columbia
2 shared publications - Hong Bing Yu
Molecular Genetics and Immunology, University of Kansas Medical Centre
2 shared publications - Qiaochu Liang
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, The University of British Columbia
2 shared publications - Ashley Gilliland
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, The University of British Columbia
1 shared publication Candice Quin
Affiliation Department of Biology, University of British Columbia, Kelowna, British Columbia, Canada
1 shared publication
Latest Publications
- Open Access
- 15 April 2026
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (4) , e0054525
The growth and pathogenesis of Citrobacter rodentium are compromised when multiple mucin sugar utilization pathways are disrupted, leading to accumulation of N-acetylglucosamine 6-phosphate
Many enteric bacterial pathogens, including attaching/effacing (A/E) Escherichia coli strains, cause acute gastroenteritis in humans. Considering the highly competitive nature of the mammalian gastrointestinal (GI) tract, these pathogens must rely on specific metabolic adaptations to establish successful infections. We hypothesized that A/E pathogens exploit host-derived nutrients within GI mucus, including N-acetylglucosamine (GlcNAc) and N-acetylneuraminic acid (NeuNAc), to fuel their pathogenesis. To address this hypothesis, we disrupted both GlcNAc and NeuNAc metabolic pathways in Citrobacter rodentium, a murine-specific A/E pathogen, by deleting nagA , which encodes the GlcNAc-6-phosphate (GlcNAc-6P) deacetylase that converts GlcNAc-6P into glucosamine-6-phosphate (GlcN-6P). Compared to wild-type (WT) C. rodentium , the Δ nagA mutant showed severely attenuated colonization and pathogenesis in C57BL/6J mice. Although Δ nagA cannot catabolize GlcNAc and NeuNAc, its in vivo defect could not be explained by nutrient deprivation alone. Instead, Δ nagA exhibited higher levels of cytosolic GlcNAc-6P, slower growth rate when cultured in vitro , altered regulation of GlcN-6P synthesis, and increased susceptibility to cell wall-targeting stressors. Supplementation with glucosamine (GlcN, which can be directly converted into GlcN-6P) partially restored the growth and resistance to cell wall stress of Δ nagA without reducing GlcNAc-6P accumulation, indicating that dysregulated GlcN-6P synthesis rather than GlcNAc-6P toxicity underlies its phenotype. Together, these data reveal a previously unrecognized metabolic vulnerability in C. rodentium where the disruption of the GlcNAc and NeuNAc metabolic pathways, by inactivating NagA, creates a sugar-phosphate imbalance that compromises cell wall integrity and pathogen fitness. Hence, targeting sugar-phosphate stress responses may provide a new therapeutic strategy against GI bacterial pathogens.
- 15 April 2026
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (4) , e0054525
Open AccessThe growth and pathogenesis of Citrobacter rodentium are compromised when multiple mucin sugar utilization pathways are disrupted, leading to accumulation of N-acetylglucosamine 6-phosphate
Many enteric bacterial pathogens, including attaching/effacing (A/E) Escherichia coli strains, cause acute gastroenteritis in humans. Considering the highly competitive nature of the mammalian gastrointestinal (GI) tract, these pathogens must rely on specific metabolic adaptations to establish successful infections. We hypothesized that A/E pathogens exploit host-derived nutrients within GI mucus, including N-acetylglucosamine (GlcNAc) and N-acetylneuraminic acid (NeuNAc), to fuel their pathogenesis. To address this hypothesis, we disrupted both GlcNAc and NeuNAc metabolic pathways in Citrobacter rodentium, a murine-specific A/E pathogen, by deleting nagA , which encodes the GlcNAc-6-phosphate (GlcNAc-6P) deacetylase that converts GlcNAc-6P into glucosamine-6-phosphate (GlcN-6P). Compared to wild-type (WT) C. rodentium , the Δ nagA mutant showed severely attenuated colonization and pathogenesis in C57BL/6J mice. Although Δ nagA cannot catabolize GlcNAc and NeuNAc, its in vivo defect could not be explained by nutrient deprivation alone. Instead, Δ nagA exhibited higher levels of cytosolic GlcNAc-6P, slower growth rate when cultured in vitro , altered regulation of GlcN-6P synthesis, and increased susceptibility to cell wall-targeting stressors. Supplementation with glucosamine (GlcN, which can be directly converted into GlcN-6P) partially restored the growth and resistance to cell wall stress of Δ nagA without reducing GlcNAc-6P accumulation, indicating that dysregulated GlcN-6P synthesis rather than GlcNAc-6P toxicity underlies its phenotype. Together, these data reveal a previously unrecognized metabolic vulnerability in C. rodentium where the disruption of the GlcNAc and NeuNAc metabolic pathways, by inactivating NagA, creates a sugar-phosphate imbalance that compromises cell wall integrity and pathogen fitness. Hence, targeting sugar-phosphate stress responses may provide a new therapeutic strategy against GI bacterial pathogens.
- Open Access
- 3 July 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (28)
Sialic acid plays a pivotal role in licensing Citrobacter rodentium’s transition from the intestinal lumen to a mucosal adherent niche
Enteric bacterial pathogens pose significant threats to human health; however, the mechanisms by which they infect the mammalian gut in the face of daunting host defenses and an established microbiota remain poorly defined. For the attaching and effacing (A/E) bacterial family member and murine pathogen Citrobacter rodentium , its virulence strategy likely involves metabolic adaptation to the host’s intestinal luminal environment, as a necessary precursor to reach and infect the mucosal surface. Suspecting this adaptation involved the intestinal mucus layer, we found that C. rodentium was able to catabolize sialic acid, a monosaccharide derived from mucins, and utilize it as its sole carbon source for growth. Moreover, C. rodentium also sensed and displayed chemotactic activity toward sialic acid. These activities were abolished when the nanT gene, encoding a sialic acid transporter, was deleted (Δ nanT ). Correspondingly, the Δ nanT C. rodentium strain was significantly impaired in its ability to colonize the murine intestine. Intriguingly, sialic acid was also found to induce the secretion of two autotransporter proteins, Pic and EspC, which possess mucinolytic and host-adherent properties. As a result, sialic acid enhanced the ability of C. rodentium to degrade intestinal mucus (through Pic), as well as to adhere to intestinal epithelial cells (through EspC). We thus demonstrate that sialic acid, a monosaccharide constituent of the intestinal mucus layer, functions as an important nutrient and a key signal for an A/E bacterial pathogen to escape the colonic lumen and directly infect its host’s intestinal mucosa.
- 3 July 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (28)
Open AccessSialic acid plays a pivotal role in licensing Citrobacter rodentium’s transition from the intestinal lumen to a mucosal adherent niche
Enteric bacterial pathogens pose significant threats to human health; however, the mechanisms by which they infect the mammalian gut in the face of daunting host defenses and an established microbiota remain poorly defined. For the attaching and effacing (A/E) bacterial family member and murine pathogen Citrobacter rodentium , its virulence strategy likely involves metabolic adaptation to the host’s intestinal luminal environment, as a necessary precursor to reach and infect the mucosal surface. Suspecting this adaptation involved the intestinal mucus layer, we found that C. rodentium was able to catabolize sialic acid, a monosaccharide derived from mucins, and utilize it as its sole carbon source for growth. Moreover, C. rodentium also sensed and displayed chemotactic activity toward sialic acid. These activities were abolished when the nanT gene, encoding a sialic acid transporter, was deleted (Δ nanT ). Correspondingly, the Δ nanT C. rodentium strain was significantly impaired in its ability to colonize the murine intestine. Intriguingly, sialic acid was also found to induce the secretion of two autotransporter proteins, Pic and EspC, which possess mucinolytic and host-adherent properties. As a result, sialic acid enhanced the ability of C. rodentium to degrade intestinal mucus (through Pic), as well as to adhere to intestinal epithelial cells (through EspC). We thus demonstrate that sialic acid, a monosaccharide constituent of the intestinal mucus layer, functions as an important nutrient and a key signal for an A/E bacterial pathogen to escape the colonic lumen and directly infect its host’s intestinal mucosa.
- Open Access
- 5 August 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (8) , e1009719
Fasting increases microbiome-based colonization resistance and reduces host inflammatory responses during an enteric bacterial infection
Reducing food intake is a common host response to infection, yet it remains unclear whether fasting is detrimental or beneficial to an infected host. Despite the gastrointestinal tract being the primary site of nutrient uptake and a common route for infection, studies have yet to examine how fasting alters the host’s response to an enteric infection. To test this, mice were fasted before and during oral infection with the invasive bacterium Salmonella enterica serovar Typhimurium. Fasting dramatically interrupted infection and subsequent gastroenteritis by suppressing Salmonella’s SPI-1 virulence program, preventing invasion of the gut epithelium. Virulence suppression depended on the gut microbiota, as Salmonella’s invasion of the epithelium proceeded in fasting gnotobiotic mice. Despite Salmonella’s restored virulence within the intestines of gnotobiotic mice, fasting downregulated pro-inflammatory signaling, greatly reducing intestinal pathology. Our study highlights how food intake controls the complex relationship between host, pathogen and gut microbiota during an enteric infection.
- 5 August 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (8) , e1009719
Open AccessFasting increases microbiome-based colonization resistance and reduces host inflammatory responses during an enteric bacterial infection
Reducing food intake is a common host response to infection, yet it remains unclear whether fasting is detrimental or beneficial to an infected host. Despite the gastrointestinal tract being the primary site of nutrient uptake and a common route for infection, studies have yet to examine how fasting alters the host’s response to an enteric infection. To test this, mice were fasted before and during oral infection with the invasive bacterium Salmonella enterica serovar Typhimurium. Fasting dramatically interrupted infection and subsequent gastroenteritis by suppressing Salmonella’s SPI-1 virulence program, preventing invasion of the gut epithelium. Virulence suppression depended on the gut microbiota, as Salmonella’s invasion of the epithelium proceeded in fasting gnotobiotic mice. Despite Salmonella’s restored virulence within the intestines of gnotobiotic mice, fasting downregulated pro-inflammatory signaling, greatly reducing intestinal pathology. Our study highlights how food intake controls the complex relationship between host, pathogen and gut microbiota during an enteric infection.